Progenity to Present at 2020 San Antonio Breast Cancer Virtual Symposium
SAN DIEGO, Nov. 17, 2020 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record of success in developing and commercializing molecular testing products, will be presenting at the San Antonio Breast Cancer Virtual Symposium (SABCS) set to take place December 8-11, 2020.
The data presented will be a part of the event’s Spotlight Session Poster Presenters. Details of the presentation are as follows:
Title - Describing the cancer spectrum in families with CHEK2 pathogenic and likely pathogenic variants by mutation type
SABCS anticipates publishing abstracts in late November 2020 and posters on December 9, 2020. The poster presentation will also be made available on the Progenity website following the conference.
#TECHSUPERSHOW Conference Party
Key Tools of the IoT Security Trade